 Blueprint Medicines Corp NASDAQ:BPMCs stock price gapped up prior to trading on Tuesday after Robert W. Baird raised their price target on the stock from 90.00 to 100.00. The stock had previously closed at 73.30, but opened at 76.65. Robert W. Baird currently has an outperform rating on the stock. Blueprint Medicines shares last traded ... 